ReviewCancers2022

Novel Salvage Therapy Options for Initial Treatment of Relapsed/Refractory Classical Hodgkin's Lymphoma: So Many Options, How to Choose?

Radhika Takiar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.